Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling.The shortness of breath is usually worse with exercise, while lying down, and may wake the person at night.A limited ability to exercise is also a common feature. Chest pain, including angina, does not typically occur due to heart failure.
This report aims to provide a comprehensive presentation of the global market for Heart Failure Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heart Failure Therapeutics. This report contains market size and forecasts of Heart Failure Therapeutics in global, including the following market information:
Global Heart Failure Therapeutics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Heart Failure Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Diagnosis Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Heart Failure Therapeutics include Bayer, Cynokinetics, Les Laboratoires Servier, Merck & Co., Novartis, Procoralan, Bristol-Myers Squibb Company, Cardiorentis AG and CVie Therapeutics Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Heart Failure Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Heart Failure Therapeutics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Heart Failure Therapeutics Market Segment Percentages, by Type, 2022 (%)
Diagnosis
Prognosis
Treatment Options and Treatment Algorithm
Global Heart Failure Therapeutics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Heart Failure Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Medical Research Organization
Global Heart Failure Therapeutics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Heart Failure Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Heart Failure Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Heart Failure Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Cynokinetics
Les Laboratoires Servier
Merck & Co.
Novartis
Procoralan
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Orion Corporation
PhaseBio Pharmaceuticals
Market Segment by Product Type
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Outline of Major Chapters:
Chapter 1: Introduces the definition of Heart Failure Therapeutics, market overview.
Chapter 2: Global Heart Failure Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Heart Failure Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Heart Failure Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Heart Failure Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Heart Failure Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Heart Failure Therapeutics Overall Market Size
2.1 Global Heart Failure Therapeutics Market Size: 2022 VS 2032
2.2 Global Heart Failure Therapeutics Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Heart Failure Therapeutics Players in Global Market
3.2 Top Global Heart Failure Therapeutics Companies Ranked by Revenue
3.3 Global Heart Failure Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Heart Failure Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Heart Failure Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Heart Failure Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Heart Failure Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Heart Failure Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Heart Failure Therapeutics Market Size Markets, 2022 & 2032
4.1.2 Diagnosis
4.1.3 Prognosis
4.1.4 Treatment Options and Treatment Algorithm
4.2 By Type - Global Heart Failure Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Heart Failure Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Heart Failure Therapeutics Revenue, 2024-2032
4.2.3 By Type - Global Heart Failure Therapeutics Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Heart Failure Therapeutics Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Medical Research Organization
5.2 By Application - Global Heart Failure Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Heart Failure Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Heart Failure Therapeutics Revenue, 2024-2032
5.2.3 By Application - Global Heart Failure Therapeutics Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Heart Failure Therapeutics Market Size, 2022 & 2032
6.2 By Region - Global Heart Failure Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Heart Failure Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Heart Failure Therapeutics Revenue, 2024-2032
6.2.3 By Region - Global Heart Failure Therapeutics Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Heart Failure Therapeutics Revenue, 2018-2032
6.3.2 US Heart Failure Therapeutics Market Size, 2018-2032
6.3.3 Canada Heart Failure Therapeutics Market Size, 2018-2032
6.3.4 Mexico Heart Failure Therapeutics Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Heart Failure Therapeutics Revenue, 2018-2032
6.4.2 Germany Heart Failure Therapeutics Market Size, 2018-2032
6.4.3 France Heart Failure Therapeutics Market Size, 2018-2032
6.4.4 U.K. Heart Failure Therapeutics Market Size, 2018-2032
6.4.5 Italy Heart Failure Therapeutics Market Size, 2018-2032
6.4.6 Russia Heart Failure Therapeutics Market Size, 2018-2032
6.4.7 Nordic Countries Heart Failure Therapeutics Market Size, 2018-2032
6.4.8 Benelux Heart Failure Therapeutics Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Heart Failure Therapeutics Revenue, 2018-2032
6.5.2 China Heart Failure Therapeutics Market Size, 2018-2032
6.5.3 Japan Heart Failure Therapeutics Market Size, 2018-2032
6.5.4 South Korea Heart Failure Therapeutics Market Size, 2018-2032
6.5.5 Southeast Asia Heart Failure Therapeutics Market Size, 2018-2032
6.5.6 India Heart Failure Therapeutics Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Heart Failure Therapeutics Revenue, 2018-2032
6.6.2 Brazil Heart Failure Therapeutics Market Size, 2018-2032
6.6.3 Argentina Heart Failure Therapeutics Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Heart Failure Therapeutics Revenue, 2018-2032
6.7.2 Turkey Heart Failure Therapeutics Market Size, 2018-2032
6.7.3 Israel Heart Failure Therapeutics Market Size, 2018-2032
6.7.4 Saudi Arabia Heart Failure Therapeutics Market Size, 2018-2032
6.7.5 UAE Heart Failure Therapeutics Market Size, 2018-2032
7 Heart Failure Therapeutics Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Heart Failure Therapeutics Major Product Offerings
7.1.4 Bayer Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Cynokinetics
7.2.1 Cynokinetics Company Summary
7.2.2 Cynokinetics Business Overview
7.2.3 Cynokinetics Heart Failure Therapeutics Major Product Offerings
7.2.4 Cynokinetics Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Cynokinetics Key News & Latest Developments
7.3 Les Laboratoires Servier
7.3.1 Les Laboratoires Servier Company Summary
7.3.2 Les Laboratoires Servier Business Overview
7.3.3 Les Laboratoires Servier Heart Failure Therapeutics Major Product Offerings
7.3.4 Les Laboratoires Servier Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Les Laboratoires Servier Key News & Latest Developments
7.4 Merck & Co.
7.4.1 Merck & Co. Company Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. Heart Failure Therapeutics Major Product Offerings
7.4.4 Merck & Co. Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Merck & Co. Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Heart Failure Therapeutics Major Product Offerings
7.5.4 Novartis Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Procoralan
7.6.1 Procoralan Company Summary
7.6.2 Procoralan Business Overview
7.6.3 Procoralan Heart Failure Therapeutics Major Product Offerings
7.6.4 Procoralan Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Procoralan Key News & Latest Developments
7.7 Bristol-Myers Squibb Company
7.7.1 Bristol-Myers Squibb Company Company Summary
7.7.2 Bristol-Myers Squibb Company Business Overview
7.7.3 Bristol-Myers Squibb Company Heart Failure Therapeutics Major Product Offerings
7.7.4 Bristol-Myers Squibb Company Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.8 Cardiorentis AG
7.8.1 Cardiorentis AG Company Summary
7.8.2 Cardiorentis AG Business Overview
7.8.3 Cardiorentis AG Heart Failure Therapeutics Major Product Offerings
7.8.4 Cardiorentis AG Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Cardiorentis AG Key News & Latest Developments
7.9 CVie Therapeutics Limited
7.9.1 CVie Therapeutics Limited Company Summary
7.9.2 CVie Therapeutics Limited Business Overview
7.9.3 CVie Therapeutics Limited Heart Failure Therapeutics Major Product Offerings
7.9.4 CVie Therapeutics Limited Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.9.5 CVie Therapeutics Limited Key News & Latest Developments
7.10 Orion Corporation
7.10.1 Orion Corporation Company Summary
7.10.2 Orion Corporation Business Overview
7.10.3 Orion Corporation Heart Failure Therapeutics Major Product Offerings
7.10.4 Orion Corporation Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Orion Corporation Key News & Latest Developments
7.11 PhaseBio Pharmaceuticals
7.11.1 PhaseBio Pharmaceuticals Company Summary
7.11.2 PhaseBio Pharmaceuticals Business Overview
7.11.3 PhaseBio Pharmaceuticals Heart Failure Therapeutics Major Product Offerings
7.11.4 PhaseBio Pharmaceuticals Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.11.5 PhaseBio Pharmaceuticals Key News & Latest Developments
7.12 Market Segment by Product Type
7.12.1 Market Segment by Product Type Company Summary
7.12.2 Market Segment by Product Type Business Overview
7.12.3 Market Segment by Product Type Heart Failure Therapeutics Major Product Offerings
7.12.4 Market Segment by Product Type Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.12.5 Market Segment by Product Type Key News & Latest Developments
7.13 B-Blockers
7.13.1 B-Blockers Company Summary
7.13.2 B-Blockers Business Overview
7.13.3 B-Blockers Heart Failure Therapeutics Major Product Offerings
7.13.4 B-Blockers Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.13.5 B-Blockers Key News & Latest Developments
7.14 Calcium Channel Blockers
7.14.1 Calcium Channel Blockers Company Summary
7.14.2 Calcium Channel Blockers Business Overview
7.14.3 Calcium Channel Blockers Heart Failure Therapeutics Major Product Offerings
7.14.4 Calcium Channel Blockers Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.14.5 Calcium Channel Blockers Key News & Latest Developments
7.15 Cardiac Glycosides
7.15.1 Cardiac Glycosides Company Summary
7.15.2 Cardiac Glycosides Business Overview
7.15.3 Cardiac Glycosides Heart Failure Therapeutics Major Product Offerings
7.15.4 Cardiac Glycosides Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.15.5 Cardiac Glycosides Key News & Latest Developments
7.16 Diuretics
7.16.1 Diuretics Company Summary
7.16.2 Diuretics Business Overview
7.16.3 Diuretics Heart Failure Therapeutics Major Product Offerings
7.16.4 Diuretics Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.16.5 Diuretics Key News & Latest Developments
7.17 Morphine
7.17.1 Morphine Company Summary
7.17.2 Morphine Business Overview
7.17.3 Morphine Heart Failure Therapeutics Major Product Offerings
7.17.4 Morphine Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.17.5 Morphine Key News & Latest Developments
7.18 Vasodilators/Nitrates
7.18.1 Vasodilators/Nitrates Company Summary
7.18.2 Vasodilators/Nitrates Business Overview
7.18.3 Vasodilators/Nitrates Heart Failure Therapeutics Major Product Offerings
7.18.4 Vasodilators/Nitrates Heart Failure Therapeutics Revenue in Global Market (2018-2023)
7.18.5 Vasodilators/Nitrates Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Heart Failure Therapeutics Market Opportunities & Trends in Global Market
Table 2. Heart Failure Therapeutics Market Drivers in Global Market
Table 3. Heart Failure Therapeutics Market Restraints in Global Market
Table 4. Key Players of Heart Failure Therapeutics in Global Market
Table 5. Top Heart Failure Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Heart Failure Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Heart Failure Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Heart Failure Therapeutics Product Type
Table 9. List of Global Tier 1 Heart Failure Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Heart Failure Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Heart Failure Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Heart Failure Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Heart Failure Therapeutics Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Heart Failure Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Heart Failure Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Heart Failure Therapeutics Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Heart Failure Therapeutics Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Heart Failure Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Heart Failure Therapeutics Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Heart Failure Therapeutics Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Heart Failure Therapeutics Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Heart Failure Therapeutics Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Heart Failure Therapeutics Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Heart Failure Therapeutics Revenue, (US$, Mn), 2024-2032
Table 30. Bayer Company Summary
Table 31. Bayer Heart Failure Therapeutics Product Offerings
Table 32. Bayer Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. Cynokinetics Company Summary
Table 35. Cynokinetics Heart Failure Therapeutics Product Offerings
Table 36. Cynokinetics Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Cynokinetics Key News & Latest Developments
Table 38. Les Laboratoires Servier Company Summary
Table 39. Les Laboratoires Servier Heart Failure Therapeutics Product Offerings
Table 40. Les Laboratoires Servier Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Les Laboratoires Servier Key News & Latest Developments
Table 42. Merck & Co. Company Summary
Table 43. Merck & Co. Heart Failure Therapeutics Product Offerings
Table 44. Merck & Co. Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Merck & Co. Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Heart Failure Therapeutics Product Offerings
Table 48. Novartis Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Procoralan Company Summary
Table 51. Procoralan Heart Failure Therapeutics Product Offerings
Table 52. Procoralan Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Procoralan Key News & Latest Developments
Table 54. Bristol-Myers Squibb Company Company Summary
Table 55. Bristol-Myers Squibb Company Heart Failure Therapeutics Product Offerings
Table 56. Bristol-Myers Squibb Company Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Bristol-Myers Squibb Company Key News & Latest Developments
Table 58. Cardiorentis AG Company Summary
Table 59. Cardiorentis AG Heart Failure Therapeutics Product Offerings
Table 60. Cardiorentis AG Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Cardiorentis AG Key News & Latest Developments
Table 62. CVie Therapeutics Limited Company Summary
Table 63. CVie Therapeutics Limited Heart Failure Therapeutics Product Offerings
Table 64. CVie Therapeutics Limited Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. CVie Therapeutics Limited Key News & Latest Developments
Table 66. Orion Corporation Company Summary
Table 67. Orion Corporation Heart Failure Therapeutics Product Offerings
Table 68. Orion Corporation Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Orion Corporation Key News & Latest Developments
Table 70. PhaseBio Pharmaceuticals Company Summary
Table 71. PhaseBio Pharmaceuticals Heart Failure Therapeutics Product Offerings
Table 72. PhaseBio Pharmaceuticals Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. PhaseBio Pharmaceuticals Key News & Latest Developments
Table 74. Market Segment by Product Type Company Summary
Table 75. Market Segment by Product Type Heart Failure Therapeutics Product Offerings
Table 76. Market Segment by Product Type Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 77. Market Segment by Product Type Key News & Latest Developments
Table 78. B-Blockers Company Summary
Table 79. B-Blockers Heart Failure Therapeutics Product Offerings
Table 80. B-Blockers Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 81. B-Blockers Key News & Latest Developments
Table 82. Calcium Channel Blockers Company Summary
Table 83. Calcium Channel Blockers Heart Failure Therapeutics Product Offerings
Table 84. Calcium Channel Blockers Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 85. Calcium Channel Blockers Key News & Latest Developments
Table 86. Cardiac Glycosides Company Summary
Table 87. Cardiac Glycosides Heart Failure Therapeutics Product Offerings
Table 88. Cardiac Glycosides Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 89. Cardiac Glycosides Key News & Latest Developments
Table 90. Diuretics Company Summary
Table 91. Diuretics Heart Failure Therapeutics Product Offerings
Table 92. Diuretics Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 93. Diuretics Key News & Latest Developments
Table 94. Morphine Company Summary
Table 95. Morphine Heart Failure Therapeutics Product Offerings
Table 96. Morphine Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 97. Morphine Key News & Latest Developments
Table 98. Vasodilators/Nitrates Company Summary
Table 99. Vasodilators/Nitrates Heart Failure Therapeutics Product Offerings
Table 100. Vasodilators/Nitrates Heart Failure Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 101. Vasodilators/Nitrates Key News & Latest Developments
List of Figures
Figure 1. Heart Failure Therapeutics Segment by Type in 2022
Figure 2. Heart Failure Therapeutics Segment by Application in 2022
Figure 3. Global Heart Failure Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Heart Failure Therapeutics Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Heart Failure Therapeutics Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Heart Failure Therapeutics Revenue in 2022
Figure 8. By Type - Global Heart Failure Therapeutics Revenue Market Share, 2018-2032
Figure 9. By Application - Global Heart Failure Therapeutics Revenue Market Share, 2018-2032
Figure 10. By Type - Global Heart Failure Therapeutics Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Heart Failure Therapeutics Revenue Market Share, 2018-2032
Figure 12. By Application - Global Heart Failure Therapeutics Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Heart Failure Therapeutics Revenue Market Share, 2018-2032
Figure 14. By Region - Global Heart Failure Therapeutics Revenue Market Share, 2018-2032
Figure 15. By Country - North America Heart Failure Therapeutics Revenue Market Share, 2018-2032
Figure 16. US Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Heart Failure Therapeutics Revenue Market Share, 2018-2032
Figure 20. Germany Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 21. France Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Heart Failure Therapeutics Revenue Market Share, 2018-2032
Figure 28. China Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 32. India Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Heart Failure Therapeutics Revenue Market Share, 2018-2032
Figure 34. Brazil Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Heart Failure Therapeutics Revenue Market Share, 2018-2032
Figure 37. Turkey Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Heart Failure Therapeutics Revenue, (US$, Mn), 2018-2032
Figure 41. Bayer Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Cynokinetics Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Les Laboratoires Servier Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck & Co. Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Procoralan Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bristol-Myers Squibb Company Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Cardiorentis AG Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. CVie Therapeutics Limited Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Orion Corporation Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. PhaseBio Pharmaceuticals Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Market Segment by Product Type Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. B-Blockers Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Calcium Channel Blockers Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Cardiac Glycosides Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Diuretics Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Morphine Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Vasodilators/Nitrates Heart Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
